PD-1/PD-L1 inhibitors in treatment-naïve, advanced non-small cell lung cancer patients with < 1% PD-L1 expression: a meta-analysis of randomized controlled trials

Durgesh Wankhede, Paul Hofman, Sandeep Grover

2022Journal of Cancer Research and Clinical Oncology17 citationsDOI Open Access PDF

Topics & Concepts

Internal medicineMedicineChemotherapyHazard ratioLung cancerOncologyOdds ratioMeta-analysisConfidence intervalCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsMetastasis and carcinoma case studies

PD-1/PD-L1 inhibitors in treatment-naïve, advanced non-small cell lung cancer patients with &lt; 1% PD-L1 expression: a meta-analysis of randomized controlled trials

Topics & Concepts

PD-1/PD-L1 inhibitors in treatment-naïve, advanced non-small cell lung cancer patients with < 1% PD-L1 expression: a meta-analysis of randomized controlled trials